{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.47,
  "market_cap": 228705894400,
  "revenue_ttm": 49724438478.40884,
  "net_income_ttm": 16349826060.651896,
  "ocf_ttm": 19502634298.822758,
  "capex_ttm": 9899732788.827549,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1398919811.4396632,
  "total_debt": 15946645995.613705,
  "cash_and_equivalents": 5133574075.474552,
  "book_value_ttm": 26767753157.377296,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4545546,
  "dividend_yield": 336.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-30T12:44:12Z"
}